Nav: Home

Sex hormones skew outcomes in clinical trials -- here's how

August 09, 2016

Clinical research often excludes females from their trials under the assumption that "one size fits all," that a painkiller or antidepressant will be equally effective in subjects of either sex, but a growing number of scientists are criticizing this approach. In an Essay published August 9 in Cell Metabolism, one group argues that hormones and other variables make a difference in how potential therapeutics behave, and both males and females must be accounted for in trials to move medical advances forward.

"Right now, when you go to the doctor and you are given a prescription, it might not ever have been specifically tested in females," says Deborah J. Clegg, a Professor of Biomedical Science at Cedars-Sinai Hospital in California. "Almost all basic research--regardless of whether it involves rodent models, dogs, or humans--is predominately done in males. The majority of research is done with the assumption that men and women are biologically the same."

One reason females are excluded from studies, she says, is that across the menstrual cycle there are fluctuations in hormones such as estrogens and progesterone, in essence creating a different hormonal milieu or profile depending on the phase of cycle, which may potentially impact the research. Often overlooked in male-only studies, these sex hormones are implicated in all biological processes, including sensitivity to fatty acids, or the ability to metabolize simple sugars. These differences have implications for all clinical trials, whether they are testing the effects of a drug or a body's ability to tolerate an organ transplant.

It is important to remember that chromosomal differences also exist between the sexes, says Clegg. There is little research examining whether drugs behave differently in the presence of an XX chromosome as opposed to an XY chromosome. Even genome-wide studies often don't take chromosomes into account, even though sex chromosomes are an integral piece of an individual's genomic makeup.

While researchers appreciate that there are sex differences in disease risk, less is known about how or why these sex differences occur or how they extend to the transsexual community. Clegg's lab is currently investigating the impact of gender reassignment surgery on cardiovascular disease risk. Women are traditionally protected against cardiovascular diseases when compared to men; however, it is unclear whether a transsexual woman (a man who has transitioned to become a woman) is at a lower or higher risk for heart disease due to the presence of endogenous male chromosomes overlaid with exogenous female hormones.

"This is an important population of individuals to study, as they will begin to enlighten us about the optimal hormonal profile to protect us from disease risk not only in this population, but also with respect to men and women. It is important to begin to understand if there is a role for hormones, chromosomes, and/or their interactions with respect to disease risk.

The NIH has only recently begun addressing these issues by instating the Office of Research on Women's Health (doi:10.1038/509282a). Clegg says that though well intended, many researchers don't know how to properly include sex as a variable in their experiments. Often, they will include females in their study without addressing if they're pre- or post-menopause, whether they're on birth control pills, or if they're taking hormone blockers. These are all aspects that can impact the hormonal profile, adding another variable that's not accounted for in the experiment's outcome. "Without addressing all of these variables in your analysis, you're still not accurately reflecting the impact of hormones and chromosomes in your research," she adds.

Clegg is hopeful that in the future, clinical trials can change. "It would be great if there were drugs that were specifically tested and dosed based on sex," she says. "There are so many variables in medical research that can't be solved by placing all women, regardless of age, into one category and certainly can't be solved by excluding us completely. With the goal of personalized medicine, it is important to begin to address and focus on sex as a biological variable."
-end-
Cell Metabolism, Morselli et al.: "Sex and Gender: Critical Variables In Pre-Clinical and Clinical Medical Research" http://www.cell.com/cell-metabolism/fulltext/S1550-4131(16)30363-1

For more on Cell Metabolism's initiative on gender in metabolism (the "Rosie Project"), please visit: http://www.cell.com/cell-metabolism/fulltext/S1550-4131%2815%2900177-1

Cell Metabolism (@Cell_Metabolism), published by Cell Press, is a monthly journal that publishes reports of novel results in metabolic biology, from molecular and cellular biology to translational studies. The journal aims to highlight work addressing the molecular mechanisms underlying physiology and homeostasis in health and disease. Visit http://www.cell.com/cell-metabolism. To receive Cell Press media alerts, contact press@cell.com.

Cell Press

Related Chromosomes Articles:

How chromosomes change their shape during cell differentiation
Scientists from the RIKEN Center for Biosystems Dynamics Research have provided an explanation of how chromosomes undergo structural changes during cell differentiation.
Key similarities discovered between human and archaea chromosomes
A study led by Indiana University is the first to reveal key similarities between chromosomes in humans and archaea.
Science snapshots: Chromosomes, crystals, and drones
From Berkeley Lab: exploring human origins in the uncharted territory of our chromosomes; scientists grow spiraling new material; drones will fly for days with this new technology
Human artificial chromosomes bypass centromere roadblocks
Human artificial chromosomes (HACs) could be useful tools for both understanding how mammalian chromosomes function and creating synthetic biological systems, but for the last 20 years, they have been limited by an inefficient artificial centromere.
Does rearranging chromosomes affect their function?
Molecular biologists long thought that domains in the genome's 3D organization control how genes are expressed.
More Chromosomes News and Chromosomes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...